HLA-DR expression in human fetal intestinal epithelium

Area of Science:

• Immunology
• Developmental Biology
• Gastroenterology

Background:

• Human Leukocyte Antigen - DR (HLA-DR) expression is a key marker in immune responses.
• The developmental expression of HLA-DR in the fetal small intestine is not fully understood.

Purpose of the Study:

• To investigate the developmental expression of HLA-DR in the human fetal small intestine.
• To explore the role of local immune reactions in modulating HLA-DR expression on intestinal epithelial cells.

Main Methods:

• Analysis of HLA-DR expression in fetal small intestine tissue samples (18-22 weeks gestation).
• In situ activation of T cells in fetal intestinal explant cultures using pokeweed mitogen.
• Assessment of HLA-DR expression on the HT-29 epithelial cell line using organ culture supernatants.

Main Results:

• HLA-DR expression in villus epithelial cells begins around 18 weeks gestation, initially at villus tips and later more widespread.
• Epithelium overlying Peyer's patches consistently expressed HLA-DR.
• Activated T cells in explants increased HLA-DR expression on both villus and crypt epithelial cells.
• Supernatants from stimulated explants induced HLA-DR expression on HT-29 cells, an effect inhibited by anti-interferon gamma antibodies.

Conclusions:

• HLA-DR expression in the fetal small intestine is developmentally regulated and influenced by immune cell activity.
• Interferon gamma plays a role in mediating immune-induced HLA-DR expression on intestinal epithelial cells.